Results 1 to 10 of about 4,182 (143)
Incidence and severity of SARS-CoV-2 infection and vaccine BNT162 side effects in children and adolescents with Noonan Syndrome: a national multicentric study [PDF]
Frontiers in PediatricsBackgroundPre-existing medical conditions are known to increase the risk of severe coronavirus disease 2019 (COVID-19), even in pediatric populations. This study aimed to evaluate the symptoms and severity of COVID-19, as well as the side effects of the ...
Gabriella Pozzobon
exaly +6 more sources
Side Effects and Efficacy of COVID-19 Vaccines among the Egyptian Population
Vaccines, 2022 Background: Knowledge about a vaccine’s side effects and efficacy is important to improving public vaccine acceptance. This study aimed to detect the safety and efficacy of vaccines among the Egyptian population.
Marwa O Elgendy +2 more
exaly +4 more sources
Diagnostics, 2023 Objectives: In this prospective study, SARS-CoV−2 spike protein specific total immunoglobulin (Ig) levels were analyzed before and after BNT162 b2 mRNA booster vaccination in individuals previously administered with two doses of BBIBP-CorV vaccine in ...
Eva Rákóczi +2 more
exaly +4 more sources
Reduced neutralization efficacy against SARS-CoV-2 Omicron variant after third boost of mRNA BNT162 vaccine among liver transplant recipients [PDF]
Journal of Hepatology, 2022 Ziv Ben Ari
exaly +3 more sources
Distinct Adverse Reactions to mRNA, Inactivated Virus, and Adenovirus Vector COVID-19 Vaccines: Insights from a Cohort Study on Atopic and Non-Atopic Subjects in Brazil [PDF]
VaccinesThe emergence of COVID-19 caused by SARS-CoV-2 prompted an unprecedented global response to develop vaccines at an accelerated pace. Messenger RNA (mRNA) and adenovirus vector vaccines emerged as the frontrunners in global immunization efforts ...
Laura Alves Ribeiro Oliveira +5 more
doaj +3 more sources
Pulmonary Embolism after Vaccination with the COVID-19 Vaccine (Pfizer, BNT162b2): A Case Report
Vaccines, 2023 Pulmonary embolism causes pulmonary vascular obstruction and damages circulation, leading to death in serious cases. Various cases of thrombosis have been reported as adverse reactions after vaccination with COVID-19 vaccines, and reliable studies on ...
Eun-Ju Kim, Seok-Ju Yoo
exaly +3 more sources
Frontiers in Immunology, 2022 Broadly neutralizing ability is critical for developing the next-generation SARS-CoV-2 vaccine. We collected sera samples between December 2021-January 2022 from 113 Taiwan naïve participants after their second dose of homologous vaccine (AZD1222, mRNA ...
Chiao-Hsuan Chao +9 more
doaj +2 more sources
Epidemiologia, 2023 In Lebanon, the nationwide vaccination against COVID-19 was launched in February 2021 using the Pfizer-BioNTech vaccine and prioritizing elderly people, persons with comorbidities, and healthcare workers.
Zeina Farah, Majd Saleh, Pamela Mrad
exaly +3 more sources
Vaccines, 2022 The BNT162b2 (Pfizer BioNTech) mRNA vaccine is an effective vaccine against COVID-19 infection. Here, we report an adverse event following immunization (AEFI) in a 48-year-old female patient who presented with fasciculations, migraine auras without ...
Grgur Salai +2 more
exaly +3 more sources
Medicina (Lithuania), 2021 Background and Objectives: This study aims to evaluate the effectiveness of the BNT162b2 COVID-19 (coronavirus disease 2019) in preventing severe symptomatic laboratory-confirmed infection among healthcare workers in a real-world scenario.
Efrén Murillo-Zamora +2 more
exaly +3 more sources